NBM

nbm-logo

NBM is a privately held company offering SurfLink, a revolutionary permanent bio-mimicking surface treatment.

#Website #More

NBM

Industry:
Medical Device

Address:
Gland, Vaud, Switzerland

Country:
Switzerland

Website Url:
http://www.nbmolecules.com

Status:
Active

Contact:
+41 22 354 00 54

Email Addresses:
[email protected]


Official Site Inspections

http://www.nbmolecules.com

  • Host name: megaphone-s7.megaphone.ch
  • IP address: 212.74.179.245
  • Location: Switzerland
  • Latitude: 47.1449
  • Longitude: 8.1551
  • Timezone: Europe/Zurich

Loading ...

More informations about "NBM"

NBMolecules

Downloads The SurfLink ® surface treatment consists of a layer of phosphorous-rich molecules, which is applied to the titanium implant surface. The treated surface mimics the natural, biological environment, thus promoting cell and โ€ฆSee details»

Nano Bridging Molecules SA - BioAlps

Organization Type . Private Company. Visit website Domains. Musculoskeletal & Inflammation ... [email protected] . BioAlps Association. Avenue de Sécheron 15 1202 Geneva, โ€ฆSee details»

NBMolecules history and development of Surflink® technology

NBMolecules SurfLink technology is protected by patents owned by the UniGe and EPFL. According to a license agreement entered into with UniGe and EPFL, the university spin-off โ€ฆSee details»

NBMolecules team, directors and scientific advisory

Revolutionary surface treatment for bone anchored implants Menu. Surflink ®. Technology; Characteristics; Pre-clinical results; Clinical results; Products; CompanySee details»

Nano Bridging Molecules - Crunchbase Company Profile & Funding

Nano Bridging Molecules. Nano Bridging Molecules® SurfLink® technology has been developed over a period of 12 years by a multidisciplinary team from a number of renowned academic โ€ฆSee details»

Nano Bridging Molecules SA (NBM) | LinkedIn

Nano Bridging Molecules SA (NBM) is a privately held Swiss company founded in 2002, is dedicated to developing and commercialising advanced bio-mimicking surface treatments for โ€ฆSee details»

NBMolecules (fka suriasis) - VentureRadar

Suriasis Switzerland Private Nano Bridging Molecules (NBMolecules®), is a privately held Swiss Medical Device/Life Science Research and Development company, focusing on the โ€ฆSee details»

Nano Bridging Molecules SA - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Nano Bridging Molecules SA of Gland, VAUD. Get the latest business insights from Dun & Bradstreet.See details»

Nano Bridging Molecules - Overview, News & Competitors

NBMolecules®, a privately held Swiss Medical Device company founded in 2002, is dedicated to developing and licensing out advanced surface treatments for bone anchored implants. โ€ฆSee details»

Nano Bridging Molecules SA โ€“ Swiss Biotech

Founded in 1998, the Swiss Biotech Association represents the interests of the Swiss biotech industry. To support its members, the association works to secure favorable framework โ€ฆSee details»

Nano Bridging Molecules SA Receives CE Marking Certification for โ€ฆ

P. 2 incorporated in 2002. In 2008 it established new laboratories and offices in Canton Vaud, Switzerland. It currently employs 7 people and has entered intoSee details»

Suriasis - VentureRadar

NBMolecules (fka suriasis) Switzerland Private Nano Bridging Molecules (NBMolecules®), is a privately held Swiss Medical Device/Life Science Research and Development company, โ€ฆSee details»

Nano Bridging Molecules SA - startup.ch

Nano Bridging Molecules SA : The SurfLinkโ„ข surface treatment by NBMolecules consists of a permanently bound layer of hydrophilic phosphorous-rich molecules, which is applied to the โ€ฆSee details»

Nextsource | Company Profile | Nano Bridging Molecules

Explore the company profile of Nano Bridging Molecules (nbmolecules.com) featuring business details and insights, funding data, industry info, employee numbers, and more.See details»

Nano Bridging Molecules SA - Drug pipelines, Patents, Clinical โ€ฆ

Explore Nano Bridging Molecules SA with its drug pipeline, therapeutic area, technology platform, 2 literature.See details»

www.nbmolecules.com

%PDF-1.5 %âãÏÓ 232 0 obj > endobj 266 0 obj >/Filter/FlateDecode/ID[3B9EE2ADB92F4784B06B9B2FB68A3EE7>]/Index[232 86]/Info 231 โ€ฆSee details»

NBMolecules products, unique clinical advantage for implant โ€ฆ

Products NBMolecules ® offers SurfLink ®, a surface treatment for bone anchored implants.Through its bio-mimicking bone-like characteristics, SurfLink ® promotes โ€ฆSee details»

New Bottle Co

Design. Performance. Crafted for durability and versatility, our bottles are available in a range of sizes (50ml โ€“ 3L), shapes, and colors, offering the perfect canvas for your brand.See details»

NBMolecules' SurfLink® product clinical results

Clinical outcome. SurfLink โ„ข may significantly improve bone regeneration and fixation resulting in clear Clinical Benefits โ€“ When It Matters Mostโ„ข NBM conducted 2 split-mouth prospective โ€ฆSee details»

NBMolecules press releases

License Agreement MIS & NBM 2015.07,27; EDI Product News - Nano Bridging Molecules SurfLink Dental: EDI 1/2014; Promising dental implant technology - NBMolecules receives โ€ฆSee details»